Categories
Announcements Find Funding Large Grant Opportunities

Research Matters

NIH: Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed)

The purpose of this FOA is to support hypothesis-driven clinical research applications that are focused on discovering novel diagnostic, prognostic and/or therapeutic biomarkers for the Lewy Body Dementias.

The purpose of this funding opportunity announcement (FOA) is to support hypothesis-driven clinical research applications that are focused on discovering novel diagnostic, prognostic, and/or therapeutic biomarkers for the Lewy Body Dementias (LBD). Biomarker research must be conducted in patients with LBD, must follow Parkinson’s Disease Biomarker Program (PDBP) protocols for clinical assessment and biospecimen collection, and must be broadly shareable through the PDBP repositories.

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

Deadline: Oct. 22, 2021

More information